Citation Impact
Citing Papers
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
The Pharmacological Potential of Rutin
2016 Standout
Role of non‐selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin‐induced nephrogonadal toxicity in rats
2004
Ototoxicity: therapeutic opportunities
2005
Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods
2005
The role of copper transporters in the development of resistance to Pt drugs
2004
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney
2002
Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albumin
1990
Wearable biosensors for healthcare monitoring
2019 Standout
Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats
2002
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells
2007
Protective Effects of L‐Arginine against Cisplatin‐Induced Renal Oxidative Stress and Toxicity: Role of Nitric Oxide
2005
Risk Factors for Ischaemic Stroke
2008
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
2005 Standout
Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat
2005
Pharmacokinetics of Ropivacaine in Uremic and Nonuremic Patients After Axillary Brachial Plexus Block
2003
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs
2004
Cisplatin Binding Sites on Human Albumin
1998
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats
2004
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis
2003
Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy
2010
Silymarin Modulates Cisplatin-Induced Oxidative Stress and Hepatotoxicity in Rats
2006
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Simvastatin attenuates cisplatin-induced kidney and liver damage in rats
2006
Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis
2003
Cisplatin: a review of toxicities and therapeutic applications
2008
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
2002 Standout
Studies on the protective effect of green tea against cisplatin induced nephrotoxicity
2009
Chronic kidney disease alters intestinal microbial flora
2012 Standout
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Interaction Between Two Dicarboxylate Endogenous Substances, Bilirubin and an Uremic Toxin, 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid, on Human Serum Albumin
1999
Accumulation of furancarboxylic acids in uremic serum as inhibitors of drug binding
1988
Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin
2011
Regulation of glutathione synthesis
2008 Standout
Serum thymic factor, FTS, attenuates cisplatin nephrotoxicity by suppressing cisplatin-induced ERK activation
2005
Cisplatin Nephrotoxicity: A Review
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Propionyl-l-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model
2006
Protein Kinase C-α and ERK1/2 Mediate Mitochondrial Dysfunction, Decreases in Active Na+ Transport, and Cisplatin-induced Apoptosis in Renal Cells
2002
Molecular mechanisms of cisplatin resistance
2011 Standout
Structure of Serum Albumin
1994 Standout
DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R2
1998
X‐ray and primary structure of horse serum albumin (Equus caballus) at 0.27‐nm resolution
1993
Effect of oral administration of arabic gum on cisplatin‐induced nephrotoxicity in rats
2003
Nomenclature of the Proteins of Cows’ Milk—Sixth Revision
2004 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats
2009
CISPLATIN INDUCES ACUTE RENAL FAILURE BY IMPAIRING ANTIOXIDANT SYSTEM IN GUINEA PIGS: EFFECTS OF ANTIOXIDANT SUPPLEMENTATION ON THE CISPLATIN NEPHROTOXICITY
2002
Cellular processing of platinum anticancer drugs
2005 Standout
Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats
2003
Metabolism of Cisplatin to a Nephrotoxin in Proximal Tubule Cells
2003
Comparison between the antiproliferative effect and intracellular glutathione depletion induced by Casiopeína IIgly and cisplatin in murine melanoma B16 cells
2011
New trends for metal complexes with anticancer activity
2008 Standout
Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells
1995
Naringenin attenuates cisplatin nephrotoxicity in rats
2005
Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants
1996
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
2008 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo
2003
Interaction Mechanism Between Indoxyl Sulfate, a Typical Uremic Toxin Bound to Site II, and Ligands Bound to Site I of Human Serum Albumin
2001
On the potential of thioredoxin reductase inhibitors for cancer therapy
2006
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Cross-resistance to cisplatin in cells with acquired resistance to copper
2004
Expression of Multidrug Resistance Protein/GS-X Pump and γ-Glutamylcysteine Synthetase Genes Is Regulated by Oxidative Stress
1998
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
p53-dependent Caspase-2 Activation in Mitochondrial Release of Apoptosis-inducing Factor and Its Role in Renal Tubular Epithelial Cell Injury
2005
Protection against Cisplatin-Induced Toxicities by N-Acetylcysteine and Sodium Thiosulfate as Assessed at the Molecular, Cellular, and in Vivo Levels
2005
Salicylate Protects Hearing and Kidney Function from Cisplatin Toxicity without Compromising its Oncolytic Action
2002
Tumour-inhibiting platinum complexes—state of the art and future perspectives
2003
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Glutathione synthesis
2012 Standout
The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer prevention
2010 Standout
Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis
2001
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
Free radicals and antioxidants in chemotherapyinduced toxicity
1997
Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit
2009
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Elevated mitochondrial cisplatin-DNA adduct levels in rat tissues after transplacental cisplatin exposure
1997
Protective effect of procaine hydrochloride on cisplatin-induced alterations in rat kidney
2002
Cisplatin up-regulates the in vivo biosynthesis and degradation of renal polyamines and c-Myc expression
2004
Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
1988 StandoutScience
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Protein Oxidation and Aging
1992 StandoutScience
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Pharmacokinetics of Ropivacaine in Uremic and Nonuremic Patients After Axillary Brachial Plexus Block
2003
In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes
2005
Nonenzymatic Covalent Posttranslational Modification of Proteins In Vivo
1985
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
2002 Standout
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
1997 Standout
Organometallic Anticancer Compounds
2010 Standout
The Diagnostic Applications of Saliva — A Review
2002
Cisplatin binding to human serum albumin: a structural study
2015
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals
2014 Standout
The events that occur when cisplatin encounters cells
1996
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Targeted Killing of Cancer Cellsin Vivoandin Vitrowith EGF-Directed Carbon Nanotube-Based Drug Delivery
2009
Evolution of serum albumin
1977 StandoutNobel
Protective effects of α-tocopherol and tiopronin against cisplatin-induced ototoxicity
2004
Protective Effects of Capsaicin against Cisplatin-Induced Nephrotoxicity in Rats
2005
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Dynamic Kinetic Resolution of Racemic β-Haloalcohols: Direct Access to Enantioenriched Epoxides
2008 StandoutNobel
The Mechanism of Mineralocorticoid Action of Carbenoxolone*
1982
Metallic implant biomaterials
2014 Standout
Superoxide dismutase from Bacillus stearothermophilus. Complete amino acid sequence of a manganese enzyme
1980 StandoutNobel
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Cisplatin-Induced Nephrotoxicity in Porcine Proximal Tubular Cells: Mitochondrial Dysfunction by Inhibition of Complexes I to IV of the Respiratory Chain
1997
Interactions of antitumoral platinum-group metallodrugs with albumin
2002
Intestinal bacteria-derived putrefactants in chronic renal failure
2002
Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.
2002
Binding of cortisol to human albumin and serum: The effect of protein concentration
1981
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of W E Lindup being referenced
Reduction of Cisplatin Nephrotoxicity by Procainamide: Does the Formation of a Cisplatin-Procainamide Complex Play a Role?
2000
Effects of procaine and two of its metabolites on cisplatin-induced kidney injury in vitro: Mitochondrial aspects
1994
Differential Effects of Cisplatin on the Production of NADH‐Dependent Superoxide and the Activity of Antioxidant Enzymes in Rat Renal Cortical Slices in vitro
1996
Role of calcium in cisplatin-induced cell toxicity in rat renal cortical slices
1996
Cisplatin nephrotoxicity: Decreases in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices
1994
Cisplatin combined with tiopronin or sodium thiosulfate
1999
Lopinavir Protein Binding In Vivo Through the 12-Hour Dosing Interval
2004
Cisplatin-induced nephrotoxicity in vitro: increases in cytosolic calcium concentration and the inhibition of cytosolic and mitochondrial protein kinase C
1996
Effect of β-carboline derivatives on the binding of l-tryptophan and diazepam to bovine and human albumin
1991
Tiopronin Protects against the Nephrotoxicity of Cisplatin in Rat Renal Cortical Slicesin Vitro
1996
Cisplatin-albumin complex for treatment of cancer of the head and neck
1992
Plasma clearance in the rat of a furan dicarboxylic acid which accumulates in uremia
1996
Decreased drug binding in uraemia: Effect of indoxyl sulphate and other endogenous substances on the binding of drugs and dyes to human albumin
1982
Amelioration of Cisplatin Toxicity in Rat Renal Cortical Slices by Dithiothreitol In vitro
1994
Drug binding defect of uraemic plasma: Unlikely involvement of carbamoylated albumin
1982
Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
2001
Drug-Albumin Binding
1975
Binding of phenytoin,l-tryptophan and O-methyl red to albumin. unexpected effect of albumin concentration on the binding of phenytoin and l-tryptophan
1978
Comparison of the toxicities of cisplatin and a new cisplatin-procaine complex to rat renal cortical slices
1996
Measurement of Platinum in Saliva of Patients Treated with Cisplatin
1999
Synthesis and Physicochemical Properties of the Furan Dicarboxylic Acid, 3-Carboxy-4-methyl-5-propyl-2-furanpropanoic Acid, an Inhibitor of Plasma Protein Binding in Uraemia
1996
Failure of a 21-Aminosteroid Antioxidant to Ameliorate Cisplatin-Induced Nephrotoxicity
1991
EFFECT OF CARBENOXOLONE ON THE CONCENTRATIONS OF ALDOSTERONE IN RAT PLASMA AND KIDNEY
1979
Phase I trial of a cisplatin‐albumin complex for the treatment of cancer of the head and neck.
1992
Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia.
1992
DECREASED BINDING OF DRUGS AND DYES TO PLASMA PROTEINS FROM RATS WITH ACUTE RENAL FAILURE: EFFECTS OF URETER LIGATION AND INTRAMUSCULAR INJECTION OF GLYCEROL
1979
Cisplatin-induced Changes in Adenine Nucleotides in Rat Kidney Slices: Amelioration by Tiopronin and Procaine
1997
Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices
1993
Tiopronin protects against the nephrotoxicity of cisplatin in the rat
1999
Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
1991
Radiopharmaceuticals: Structure-Activity Relationships
1982
Plasma protein binding of drugs-some basic and chemical aspects
1987
Hypothesis: Is Accumulation of a Furan Dicarboxylic Acid (3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid) Related to the Neurological Abnormalities in Patients with Renal Failure?
1996